Drug profile · INN
tolmetin sodium
TOLECTIN DS
tolmetin sodium (TOLECTIN DS) is a cyclooxygenase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — tolmetin sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
tolmetin sodium (TOLECTIN DS) is a cyclooxygenase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is tolmetin sodium?
tolmetin sodium (TOLECTIN DS) is a cyclooxygenase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tolmetin sodium?
TOLECTIN DS is a marketed brand name for tolmetin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tolmetin sodium?
tolmetin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.